Mifepristone: US Supreme Court rejects ban on abortion drug

Janice Hopkins Tanne
DOI: https://doi.org/10.1136/bmj.q1321
2024-06-15
BMJ
Abstract:The US Supreme Court has unanimously rejected a case to restrict access to the abortion drug mifepristone. The Alliance for Hippocratic Medicine, an anti-abortion group in Texas, had asked the court to ban the drug and force the Food and Drug Administration to take it off the market. The case had been appealed from lower courts.1On 13 June the Supreme Court rejected the case on technical grounds, stating that the alliance did not have legal standing to sue because doctors who were used as examples by the group to support its case were not harmed. They did not use or prescribe the drug or treat patients taking it, nor were they harmed by the drug remaining on the market. US physicians who object to abortions are protected from treating patients seeking abortion.The court did not rule on the main point: that the FDA had wrongly approved the drug, that it...
medicine, general & internal
What problem does this paper attempt to address?